| Sources | Names Used |
|---|---|
| CCLE, GDSC1000, GRAY, FIMM, UHNBreast | Erlotinib |
| gCSI, CTRPv2 | erlotinib |
| PharmacoGx | Erlotinib |
| Database | Identifier |
|---|---|
| Smiles: | COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl |
| Inchikey: | GTTBEUCJPZQMDZ-UHFFFAOYSA-N |
| Pubchem: | 176871 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGFBP1 | GDSC1000 | pan-cancer | AAC | 0.35 | 3e-09 |
| mRNA | HS3ST1 | CCLE | pan-cancer | AAC | 0.32 | 3e-09 |
| mRNA | IVL | CCLE | pan-cancer | AAC | 0.28 | 3e-09 |
| mRNA | EPS8L2 | GDSC1000 | pan-cancer | AAC | 0.37 | 3e-09 |
| mRNA | SYTL1 | CCLE | pan-cancer | AAC | 0.29 | 3e-09 |
| mRNA | RHBDL2 | CCLE | pan-cancer | AAC | 0.3 | 3e-09 |
| mRNA | TACSTD2 | gCSI | pan-cancer | AAC | 0.39 | 3e-09 |
| mRNA | CLDN4 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-09 |
| mRNA | MAP7 | CCLE | pan-cancer | AAC | 0.33 | 4e-09 |
| mRNA | FA2H | CCLE | pan-cancer | AAC | 0.3 | 4e-09 |
